4//SEC Filing
Chen Hubert C 4
Accession 0001209191-23-051484
CIK 0001419041other
Filed
Oct 2, 8:00 PM ET
Accepted
Oct 3, 4:29 PM ET
Size
9.4 KB
Accession
0001209191-23-051484
Insider Transaction Report
Form 4
Chen Hubert C
See remarks
Transactions
- Exercise/Conversion
Restricted Stock Units
2023-10-01−7,500→ 97,500 total→ Common Stock (7,500 underlying) - Exercise/Conversion
Common Stock
2023-10-01+7,500→ 91,571 total - Tax Payment
Common Stock
2023-10-01$0.66/sh−2,593$1,717→ 88,978 total
Footnotes (3)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of Forte Biosciences, Inc. Common Stock.
- [F2]On October 1, 2023, the Reporting Person's RSUs vested. The closing price of Forte Biosciences, Inc.'s Common Stock on September 29, 2023 was the settlement price used to calculate the shares withheld.
- [F3]Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, one-sixteenth (1/16th) of the RSUs subject to the award shall vest on each Quarterly Vesting Date (as defined below) on or immediately following February 1, 2023. For purposes of this RSU Award, "Quarterly Vesting Date" with respect to any calendar year means January 1, April 1, July 1, and October 1.
Documents
Issuer
Forte Biosciences, Inc.
CIK 0001419041
Entity typeother
Related Parties
1- filerCIK 0001622297
Filing Metadata
- Form type
- 4
- Filed
- Oct 2, 8:00 PM ET
- Accepted
- Oct 3, 4:29 PM ET
- Size
- 9.4 KB